Insider Transactions in Q2 2023 at Yumanity Therapeutics, Inc. (YMTX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2023
|
Keith Baker Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+29.62%
|
$10,000
$2.92 P/Share
|
|
Jun 14
2023
|
Shawn Iadonato |
SELL
Payment of exercise price or tax liability
|
Direct |
7,439
-1.11%
|
$14,878
$2.82 P/Share
|
|
Jun 14
2023
|
Shawn Iadonato |
BUY
Exercise of conversion of derivative security
|
Direct |
1,382
+0.21%
|
$0
$0.14 P/Share
|
|
Jun 14
2023
|
Pauline Kenny General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
858
-4.82%
|
$1,716
$2.82 P/Share
|
|
Jun 14
2023
|
Craig W. Philips President and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
12,666
-18.91%
|
$25,332
$2.82 P/Share
|
|
Jun 14
2023
|
Craig W. Philips President and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,382
+3.84%
|
$0
$0.14 P/Share
|
|
Jun 14
2023
|
Raymond J. Bartoszek |
BUY
Exercise of conversion of derivative security
|
Indirect |
60,018
+6.64%
|
$0
$0.14 P/Share
|